Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Scientists found a new, less invasive way to study body clocks using hair cells, which shows shift workers' body clocks don't match their lifestyles.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

UV radiation can help sterilize wounds and promote healing but requires careful use to avoid damaging cells.

Fullerenes show potential in skin care but need more safety research.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Santolina chamaecyparissus oil effectively fights fungal infections.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

Peptides, proteins, and growth factors in skincare show promise for improving skin health.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Topical JAK inhibitors may help treat some skin conditions but need more research.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Melatonin may help treat PCOS symptoms in rats.